pI: 8.843 |
Length (AA): 651 |
MW (Da): 73732 |
Paralog Number:
2
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 9 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
235 | 597 | 3kvw (A) | 75 | 462 | 45.00 | 0 | 1 | 1.1097 | -0.77 |
240 | 599 | 5y86 (A) | 140 | 524 | 44.00 | 0 | 1 | 1.1031 | -0.95 |
270 | 508 | 4wih (A) | 0 | 239 | 27.00 | 0.00000000012 | 1 | 0.551228 | 0.48 |
285 | 599 | 4ylk (A) | 136 | 481 | 38.00 | 0 | 1 | 0.960971 | -0.92 |
302 | 649 | 4fr4 (A) | 17 | 343 | 21.00 | 0 | 1 | 0.670662 | 0.39 |
304 | 643 | 3nyv (A) | 47 | 363 | 28.00 | 0 | 1 | 0.731373 | 0.16 |
307 | 642 | 1tki (A) | 23 | 318 | 27.00 | 0 | 1 | 0.712229 | -0.04 |
391 | 501 | 4ix3 (A) | 265 | 410 | 38.00 | 0.00023 | 0.99 | 0.347607 | -0.26 |
430 | 504 | 5xd6 (A) | 195 | 272 | 52.00 | 0.0011 | 0.57 | 0.240307 | 1.54 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_127439)
Species | Accession | Gene Product |
---|---|---|
Brugia malayi | Bm1_38345 | Dual-specificity tyrosine-phosphorylation regulated kinase 2 |
Candida albicans | CaO19.5253 | weaker similarity to S. cerevisiae YAK1 (YJL141C) |
Candida albicans | CaO19.12718 | weaker similarity to S. cerevisiae YAK1 (YJL141C) |
Caenorhabditis elegans | CELE_F49E11.1 | Protein MBK-2, isoform D |
Dictyostelium discoideum | DDB_G0293750 | DYRK family protein kinase |
Drosophila melanogaster | Dmel_CG40478 | Dual-specificity tyrosine phosphorylation-regulated kinase 3 |
Drosophila melanogaster | Dmel_CG4551 | Dual-specificity tyrosine phosphorylation-regulated kinase 2 |
Echinococcus granulosus | EgrG_000716900 | dual specificity |
Echinococcus granulosus | EgrG_000352000 | dual specificity |
Echinococcus granulosus | EgrG_000101500 | dual specificity |
Entamoeba histolytica | EHI_062780 | protein kinase domain containing protein |
Entamoeba histolytica | EHI_004780 | protein kinase, putative |
Echinococcus multilocularis | EmuJ_000352000 | dual specificity |
Echinococcus multilocularis | EmuJ_000716900 | dual specificity |
Echinococcus multilocularis | EmuJ_000101500 | dual specificity |
Giardia lamblia | GL50803_17417 | Kinase, CMGC DYRK |
Homo sapiens | ENSG00000010219 | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 4 |
Homo sapiens | ENSG00000143479 | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 3 |
Homo sapiens | 8445 | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 |
Leishmania braziliensis | LbrM.33.2090 | protein kinase, putative,dual-specificity protein kinase, putative |
Leishmania donovani | LdBPK_331930.1 | dual-specificity protein kinase, putative |
Leishmania infantum | LinJ.33.1930 | protein kinase, putative,dual-specificity protein kinase, putative |
Leishmania major | LmjF.33.1830 | protein kinase, putative,dual-specificity protein kinase, putative |
Leishmania mexicana | LmxM.34.1860 | protein kinase-like protein |
Leishmania mexicana | LmxM.32.1830 | protein kinase, putative,dual-specificity protein kinase, putative |
Loa Loa (eye worm) | LOAG_06784 | CMGC/DYRK/DYRK2 protein kinase |
Mus musculus | ENSMUSG00000030345 | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 4 |
Mus musculus | ENSMUSG00000028630 | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 |
Mus musculus | 226419 | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 3 |
Neospora caninum | NCLIV_069610 | hypothetical protein |
Schistosoma japonicum | Sjp_0051010 | ko:K08825 dual-specificity tyrosine-(Y)-phosphorylation regulated kinase, putative |
Schistosoma mansoni | Smp_141230 | serine/threonine protein kinase |
Schmidtea mediterranea | mk4.003062.01 | |
Schmidtea mediterranea | mk4.001090.03 | |
Schmidtea mediterranea | mk4.008864.00 | |
Schmidtea mediterranea | mk4.000301.12 | Dual specificity tyrosine-phosphorylation-regulated kinase mbk-2 |
Schmidtea mediterranea | mk4.000792.04 | |
Schmidtea mediterranea | mk4.001940.03 | |
Schmidtea mediterranea | mk4.009745.00 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 |
Trypanosoma brucei gambiense | Tbg972.11.3480 | protein kinase, putative,dual-specificity protein kinase, putative |
Trypanosoma brucei | Tb927.11.3140 | dual specificity tyrosine-phosphorylation-regulated kinase 2, putative |
Trypanosoma congolense | TcIL3000.11.2930 | dual-specificity protein kinase, putative |
Trypanosoma cruzi | TcCLB.510431.140 | dual specificity tyrosine-phosphorylation-regulated kinase 2, putative |
Toxoplasma gondii | TGME49_283480 | cell-cycle-associated protein kinase DYRK2, putative |
Trichomonas vaginalis | TVAG_449760 | CMGC family protein kinase |
Trichomonas vaginalis | TVAG_185330 | CMGC family protein kinase |
Trichomonas vaginalis | TVAG_373280 | CMGC family protein kinase |
Trichomonas vaginalis | TVAG_003360 | CMGC family protein kinase |
Trichomonas vaginalis | TVAG_242930 | CMGC family protein kinase |
Trichomonas vaginalis | TVAG_267730 | CMGC family protein kinase |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb11.02.0640 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb11.02.0640 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb11.02.0640 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb11.02.0640 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_F49E11.1 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_F49E11.1 | Caenorhabditis elegans | sterile | wormbase |
TGME49_283480 | Toxoplasma gondii | Essentiality uncertain | sidik |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 3 | Compounds | References |
Homo sapiens | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 | Compounds | References |
Homo sapiens | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 4 | Compounds | References |
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Schizosaccharomyces pombe 972h- | Casein kinase II subunit alpha | 332 aa | 27.2% | 316 aa | Compounds | References |
Rattus norvegicus | MAP kinase p38 alpha | 360 aa | 31.6% | 304 aa | Compounds | References |
Patiria pectinifera | Cdc2 | 300 aa | 27.5% | 302 aa | Compounds | References |
Zea mays | Casein kinase II alpha | 332 aa | 25.9% | 320 aa | Compounds | References |
Rattus norvegicus | Serine/threonine-protein kinase pim-3 | 326 aa | 24.8% | 303 aa | Compounds | References |
Xenopus laevis | Aurora kinase B-B | 368 aa | 25.6% | 297 aa | Compounds | References |
Xenopus laevis | Aurora kinase B-A | 361 aa | 24.9% | 297 aa | Compounds | References |
Rattus norvegicus | Jak1 protein | 210 aa | 23.3% | 180 aa | Compounds | References |
Rattus norvegicus | Mitogen-activated protein kinase 1 | 358 aa | 31.7% | 312 aa | Compounds | References |
Homo sapiens | Cyclin-dependent kinase 1/cyclin B1 | 297 aa | 28.8% | 295 aa | Compounds | References |
Plasmodium falciparum (isolate 3D7) | Cell division control protein 2 homolog | 288 aa | 28.5% | 295 aa | Compounds | References |
Rattus norvegicus | Cell division protein kinase 5 | 292 aa | 30.3% | 297 aa | Compounds | References |
Rattus norvegicus | Mitogen-activated protein kinase 8 | 411 aa | 30.9% | 362 aa | Compounds | References |